CITATION STYLE
Canal, N., & Franceschi, M. (1994). Eptastigmine (MF-201). A Double-Blind, Placebo-Controlled, Clinical Trial in Alzheimer Disease Patients. In Alzheimer Disease (pp. 108–112). Birkhäuser Boston. https://doi.org/10.1007/978-1-4615-8149-9_19
Mendeley helps you to discover research relevant for your work.